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To study the role of basic helix–loop–helix (bHLH) transcription factors in gliogenesis, we examined whether bHLH
transcription factors were expressed in glial precursor cells and participated in regulating oligodendrocyte and astrocyte
development. As assessed by reverse transcription–polymerase chain reaction (RT-PCR), Neurogenin3 (Ngn3) was
transiently expressed in bipotential glial cells fated to become either oligodendrocytes or astrocytes. Mice lacking Ngn3
displayed a loss of Nkx2.2 expression, a transcription factor required for proper oligodendrogliogenesis. Furthermore, a
reduction in the expression of myelin basic protein (MBP), proteolipid protein (PLP), and glial fibrillary acidic protein
(GFAP), markers for mature oligodendrocytes and astrocytes, was observed in the Ngn3 null mice. Overexpression of Ngn3
was sufficient to drive expression from the PLP promoter in transient cotransfection assays. Overall, the data suggest that
Ngn3 may regulate glial differentiation at a developmental stage prior to the segregation of the oligodendrocyte and
astrocyte lineage. © 2003 Elsevier Science (USA)
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cord.INTRODUCTION
Multipotent neural stem cells of the central nervous
system (CNS) differentiate to generate neurons, astrocytes,
and oligodendrocytes of the vertebrate spinal cord (Gage et
al., 1995; Kalyani and Rao, 1998; Weiss et al., 1996). The
appearance of these cells occurs in a highly specific manner,
both temporally and spatially. Evidence from our laboratory
suggests that oligodendrocytes and astrocytes differentiate
from multipotent neuroepithelial stem cells (NEPs) via
intermediary precursor cells termed glial restricted precur-
sor cells (GRPs) (Lee et al., 2000; Rao and Mayer-Proschel,
1997).
Oligodendrocytes are believed to originate from GRPs,
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84specifically oligodendrocyte precursors cells (OLPs), resid-
ing adjacent to the floor plate in the ventral neural tube
(Hall et al., 1996; Timsit et al., 1995). Early markers for glial
precursors appear in two distinct ventral domains of the
murine neural tube (see Fig. 1) (Pringle and Richardson,
1993; Spassky et al., 1998). One domain of precursors
appears to be A2B5/PLP-DM20/Nkx2.2: this population
can generate astrocytes and oligodendrocytes but not neu-
ronal phenotypes in vitro and in vivo (Fu et al., 2002; Qi et
al., 2001; Rao and Mayer-Proschel, 1997; Rao et al., 1998;
Spassky et al., 1998). The other domain of glial precursors
appears to be A2B5/PDGFR/Olig1/Olig2: these cells
are capable of generating oligodendrocytes as well (Lu et al.,
2000; Zhou et al., 2000).
Astrocytes are first observed in the murine neural tube
beginning at around E16 based on GFAP immunoreactivity
(Bignami and Dahl, 1974; Oudega and Marani, 1991); ex-
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pression of S100, another astrocyte-specific marker (Ghan-
dour et al., 1981), is seen in regions that partially overlap
areas of GFAP expression. Cells that generate only astro-
cytes have not yet been demonstrated in the caudal neural
tube, although they have been isolated from the optic nerve
and cerebellum (Mi and Barres, 1999; Seidman et al., 1997).
Hall et al. (1996) have demonstrated the existence of an
A2B5/PDGFR/GFAP cell that appears similar in prop-
erty to cells isolated by Mi and Barres (1999) that can
generate astrocytes in culture. Whether GRPs generate
astrocyte precursor cells, which in turn generate astrocytes,
remains to be determined.
The ability of precursor cells to differentiate into oligo-
dendrocytes and astrocytes likely depends on signals from
organizing structures of the ventral midline (Ericson et al.,
1995; Lee et al., 2000; McMorris and McKinnon, 1996;
Tanabe and Jessell, 1996; Wegner, 2000). Two families of
transcription factors that function during differentiation
include homeodomain and bHLH proteins. Nkx2.2, an Nkx
homeobox gene, is expressed in the ventral neural tube
adjacent to the floor plate (Shimamura et al., 1995), and its
expression persists postnatally (Qi et al., 2001). Nkx2.2 has
been shown to be important in regulating oligodendrocyte
differentiation. Studies in chick embryos show that oligo-
dendrocytes arise from Nkx2.2 cells (Soula et al., 2001; Xu
et al., 2000), while genetically altered mice that lack
Nkx2.2 exhibit a reduction and delay in the appearance of
several markers for oligodendrocytes (Qi et al., 2001). The
loss of Nkx2.2 specifically affects oligodendrocytes with no
measurable loss of astrocytes or neurons (Qi et al., 2001).
Initial analysis of other members of the Nkx homeobox
family expressed in the ventral neural tube, such as Nkx6.1
or Nkx6.2, demonstrates that only Nkx2.2 appears to be
expressed by OLPs (Cai et al., 2001; Sussel et al., 1999; Xu
et al., 2000), thus suggesting that Nkx2.2 specifically affects
oligodendrocyte development in the spinal cord.
In recent years, bHLH transcription factors have been
implicated in the determination and differentiation of glia.
In particular, the olig family of bHLH transcription factors
has been identified as being regulators of oligodendrocyte
specification and development (Lu et al., 2000; Zhou et al.,
2000). Olig1 and olig2 are initially expressed in a domain
distinct from Nkx2.2’s domain of expression, though at
later stages they are coexpressed (Lu et al., 2000). Gain-of-
function experiments demonstrate that olig1/2 can induce
the expression of the early oligodendrocyte-specific genes
(Lu et al., 2000; Zhou et al., 2000). Coordinate expression of
Nkx2.2 and olig2 induces the appearance of cells of the
oligodendrocyte lineage (Sun et al., 2001a; Zhou et al.,
2001). In loss-of-function experiments, the double knock-
out and olig2 null mice demonstrate a loss of motor
neurons and oligodendrocytes, while the olig1 null displays
a partial oligodendrocyte phenotype (Lu et al., 2002; Zhou
and Anderson, 2002). Thus, it appears that genes from both
domains, Nkx2.2 and olig1/2, are required for the proper
appearance of oligodendrocytes in the vertebrate CNS.
FIG. 1. Oligodendrocytes and their precursors appear to arise from two distinct domains within the ventral neural tube. Based on data
from several groups, two domains likely give rise to oligodendrocytes. One domain is defined by Nkx2.2 expression (1), while the other
domain expresses olig1/2, sox10, and PDGFR (2). Both domains express A2B5. As development progresses, oligodendrocyte precursors
from both domains converge and begin to migrate toward the prospective white matter. Once these cells start to express NG2, they have
committed to becoming oligodendrocytes. NG2 cells progressively mature, acquiring GalC immunoreactivity, and by E18, they begin to
express mature oligodendrocyte markers. We note that the two persistent populations of precursors exist throughout embryonic
development and into the postnatal animal. The ages shown correspond to murine development. It is unknown whether GalC cells
express olig1/2. vz, ventricular zone.
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Other bHLH genes may also be important in glial devel-
opment (Vetter, 2001). Barres and colleagues have demon-
strated that oligodendrocyte lineage cells express both
Mash1 and Id2, but only Id2 is required for proper oligoden-
drocyte development (Wang et al., 2001). Other studies
have demonstrated a role for bHLH proteins during astro-
cyte development. Sun et al. (2001b) report that Ngn1
inhibits astrocyte differentiation by preventing the activa-
tion of a transcription complex necessary for glial differen-
tiation. Mice lacking both Ngn2 and Mash1 display a
premature and excessive differentiation of astrocytic pre-
cursors at the apparent expense of neuronal precursors
(Nieto et al., 2001).
In this report, we sought to identify bHLH proteins
present in immunopurified GRPs isolated from the spinal
cord, which may function during gliogenesis. Among the
proteins we identified was Ngn3. Ngn3 is a bHLH transcrip-
tion factor expressed in the ventral neural tube at a time of
neurogenesis and gliogenesis (Cau et al., 1997; Ravassard et
al., 1997a; Sommer et al., 1996). We found that Ngn3
expression was coincident with early gliogenesis and was
detected in the same ventral domain where Nkx2.2 is
expressed. In the absence of Ngn3, expression of Nkx2.2
and the V3 interneuron marker Sim1 was disrupted; how-
ever, motor neurons as assessed by Isl1 expression appeared
normal. The loss of Nkx2.2 and Sim1 in the Ngn3 knockout
mouse was not due to an increase in apoptotic cell death
since TdT-mediated dUTP nick-end labeling (TUNEL) re-
vealed no difference between the genotypes analyzed. In
addition to the loss of Nkx2.2, expression of MBP, PLP, and
GFAP was delayed and reduced in the Ngn3 null mouse. In
fibroblast transfection experiments, Ngn3 was capable of
driving GFP expression from the PLP promoter but not the
GFAP promoter. These results thus suggest a role for Ngn3
in the differentiation of glial precursors into both oligoden-
drocytes and astrocytes.
FIG. 2. NeuroD, NeuroD2, and Ngn3 can be identified in glial
precursor cells. Degenerate PCR using primers to the conserved
helix domain was performed as described in Materials and Methods
by using immunopanned GRP cells. (A) Multiple clones of three
different bHLH proteins were identified. (B) The expression of
Ngn3, NeuroD, and NeuroD2 in GRPs was confirmed by using
gene-specific primers. The specificity of the primers was confirmed
by using cDNA from spinal cord (SC). To confirm glial expression
of these bHLH genes and rule out neuronal contamination, gene-
specific PCR primers were used to detect expression in an immor
talized glial precursor cell line (GRP CL) and in purified O2A glial
precursor cells isolated from the optic nerve (C, D). (C) NeuroD,
NeuroD2, and Ngn3 could be readily detected in both cell popula-
tion but not in control assays where no cDNA was added. (D) To
rule out any potential neuronal contamination, primers to nestin,
PLP/DM20, NF-M, GFAP, and the housekeeping gene G3DPH
were used to detect expression of neuronal and glial markers in
aliquots of cDNA from the GRP CL and O2A cells. Whole brain
(WB) cDNA was used as a positive control. NF-M was readily
detected in only WB, indicating that the GRP CL and O2A cDNA
did not contain appreciable neuronal contamination. (E) Expression
of olig1, olig2, and Nkx2.2 was tested on cDNA derived from the
GRP CL and E14.5 SC cDNA by using gene-specific primers.
Nkx2.2 and olig1 were detected in both cDNA populations,
whereas olig2 could not be detected in the GRP CL. The GRP CL
again showed no appreciable neuronal contamination.
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FIG. 3. Ngn3 and Nkx2.2 expression can be detected in the same domain within the ventral neural tube, and Ngn3 and Nkx2.2 cells
do not coexpress neuronal markers. In situ hybridization and immunohistochemistry were performed on transverse mouse sections from
the caudal neural tube. The transient nature of Ngn3 expression is demonstrated at E10.5 (A), E12.5 (B), E13.5 (C), and E16.5 (D) via in situ
hybridization. The domain of expression for Nkx2.2 appears to overlap with Ngn3 expression at both E10.5 and E12.5 (compare A and B
with E and F). In double-labeling experiments, cells immunopositive for Ngn3 (green) and Nkx2.2 (red) are present at both E10.5 (G) and
E13.5 (H). In E14.5 rat sections, Ngn3 (red) and sox10 (green) are expressed in two distinct domains in the ventral neural tube (I). Both
Nkx2.2 (J, red) and Ngn3 (K, red) did not appear to colocalize with the known neuronal markers MAP2 (J, green) and III tubulin (K, green),
respectively, at E12.5 transverse mouse sections. In dissociated mixed cultures, III tubulin (green) and Nkx2.2 (red) do not colabel the same
cell (L). To demonstrate that Nkx2.2 expression is sustained in glial progenitors and is coexpressed in cells that express glial markers,
RT-PCR was performed on GRPs in nondifferentiating conditions (M). Note that the expression of Ngn3 is transient, whereas Nkx2.2
continues to be expressed. Ngn3, present initially, is substantially down-regulated, while Nkx2.2, present at low levels initially, increases
greatly after only 2 days in culture. (N) Sister dishes of immunopanned GRP cells, that expressed Ngn3 as assessed by RT-PCR from acutely
dissociated E14.5 rat neural tubes, were double stained for Nkx2.2 and the early glial marker A2B5 to determine whether glial precursors
express Nkx2.2; the nuclear stain bis-benzamide (blue) was used to stain every cell in the field. Cells expressing the glial-specific marker
A2B5 (green) also express Nkx2.2 (red). Scale bars, 50 m.
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MATERIALS AND METHODS
Animals
Both time-pregnant Sprague–Dawley rats (Simonsen) and ICR
mice (Harlan) were used in this study. The day the sperm plug was
detected was designated E0.5. The Ngn3 knockout mouse was
generated in the Guillemot laboratory (see Gradwohl et al., 2000),
while the Nkx2.2 knockout mouse was generated in the Ruben-
stein laboratory (see Sussel et al., 1998). Genotyping of the Ngn3
and Nkx2.2 mice was performed as previously described.
cDNA Synthesis and RT-PCR
To identify bHLH proteins that were expressed in glial precur-
sors of the neural tube, E13.5 rat neural tubes were dissociated and
GRPs were isolated by immunopanning (see protocol below). Cells
were cultured for 3 days before total RNA was harvested (Trizol).
Single-stranded cDNA was synthesized from the RNA (Super-
script), and two sets of degenerate primers corresponding to the
basic domain and the second helix domain were used to amplify
bHLH proteins present in GRPs. The nucleotide sequence of the
degenerate primers used were as follows: 5-CGC GGA TCC
(A/C)G(A/C/G/T) AA(C/T) GA(A/G) (A/C)G(C/G/T) GA(A/G) (A/
C)G-3, 5-CGC GGA TCC GC(A/C/G/T) AA(C/T) GC(A/C/T)
(A/C)G(C/G/T) GA(A/G) (A/C)G-3, 5-CCG GAA TTC GT(C/T)
TC(A/C/G) A(C/T)(C/T) TT(A/G) CT(A/C/G) A(A/G/T)(C/T) TT-
3, and 5-CCG GAA TTC GT(C/T) TC(A/C/G) A(C/T)(C/T) TT(A/
G/T) GA(A/C/G) A(A/G/T)(C/T) TT-3. Two rounds of PCR were
performed and the PCR fragments were subsequently subcloned
and sequenced. Table 1 lists the rat sequences of all the PCR
primers (and sizes) used in the experiments of this paper.
Immunocytochemistry and Immunohistochemistry
Immunocytochemistry and immunofluorescence were per-
formed as previously described in Rao and Mayer-Proschel (1997).
Briefly, cells were fixed in 2% paraformaldehyde for 30 min at room
temperature and washed three times with phosphate-buffered
saline (PBS). Incubation with the primary antibody diluted in
blocking buffer (PBS, 5% goat serum, 1% BSA, and 0.1% Triton)
was performed overnight. For A2B5 live cell staining, cells were
incubated with the primary antibody diluted in DMEM for 1 h at
room temperature. Cells were then rinsed three times with DMEM
prior to a 30-min room temperature incubation with the secondary
antibody. The cells were again rinsed three times with DMEM;
these cells could then be visualized for A2B5 staining and subse-
quently double stained following the protocol above.
For immunohistochemical analysis, 12- to 18-m OCT-
embedded frozen sections were collected on Superfrost microscope
slides. The sections were blocked in blocking buffer for 1 h prior to
the application of the primary antibody, which was allowed to
incubate overnight at 4°C. Slides were mounted and coverslipped
prior to microscopy.
The following antibodies were used: Ngn3 (1:4000; see Schwit-
zgebel et al., 2000 for the generation of the Ngn3 antibody); Nkx2.2
(1:5; DSHB); III tubulin (1:500; Sigma); MAP2 (1:1000; Sigma);
sox10 (1:10; Dr. Anderson); A2B5 (1:5; ATCC); Isl1 (1:50; DSHB);
Chx10 (1:1000; Dr. Levine); Pax6 (1:50; DSHB); MBP (1:25; Chemi-
con); GFAP (1:500; Dako); S100 (1:200; Sigma); and anti-myc 9e10
(1:500; Dr. Vetter). Bis-benzamide (1:1000; Sigma) was used to
identify the nuclei of cells.
Secondary antibodies were purchased from Molecular Probes or
Southern Biotechnology. Images were captured on either an Olym-
pus confocal microscope or an inverted Nikon or Olympus fluores-
cent microscope.
TABLE 1
Gene Product size (bp) Rat sequence
NeuroD 564 F: 5-CACCATGGACAGCTCCCATG-3
R: 5-GTGAACAGGAACTTTGATCCCCTG-3
NeuroD2 265 F: 5-GGCCGAAGAAACGCAAGATG-3
R: 5 GCACAGAGTCTGCACGTAGG 3
Ngn3 488 F: 5 GTGCTC AGTTCCAATTCCACC 3
R: 5 GAACTCCTCCAATGAGGCTGT 3
Olig1 154 F: 5 AAGGAGGACATTTCCAGACTTC 3
R: 5 GCTCTAAACAGGTGGGATTCATC 3
Olig2 306 F: 5 CAAGTCATCTTCCTCCAGCAC 3
R: 5 GTAGATCTCGCTCACCAGTCG 3
Nestin 222 F: 5 CTACCAGGAGCGCGTGGC 3
R: 5 TCCACAGCCAGCTGGAACTT 3
PLP/DM20 505/400 F: 5 GACATGAAGCTCTCACTGGCAC 3
R: 5 CATACATTCTGGCATCAGCC 3
NF-M 185 F: 5 GCCGAGCAGAACAAGGAGGCCATT 3
R: 5 CTGGATGGTGTCCTGGTAGCTGCT 3
GFAP 387 F: 5 GAAACCAACCTGAGGCTGGAG 3
R: 5 GGCGATAGTCATTAGCCTCG 3
G3PDH 450 F: 5 ACCACAGTCCATGCCATCAC 3
R: 5 TCCACCACCCTGTTGCTGTA 3
Nkx2.2 221 F: 5 CGAGTGGCAGATTCCATTG 3
R: 5 ATTCACGAAAGCAGTGCGG 3
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In Situ Hybridization and TUNEL Assay
Nonradioactive in situ hybridization with digoxigenin-labeled
riboprobes was performed on mouse sections according to
Schaeren-Wiemers and Gerfin-Moser (1993) with slight modifica-
tions. The following anti-sense riboprobes were used: Ngn3, Sim1,
olig2, PDGFR, sox10, MBP, and PLP. TUNEL assays were per-
formed by using a kit according to the manufacturer’s protocol
(Promega).
Constructs
Full-length Ngn3 was amplified from E13.5 rat spinal cord
cDNA, N-terminally tagged with the myc epitope, and cloned into
the retroviral vector pLNCX (Clontech). The PLP–GFP and GFAP–
GFP promoter–reporter constructs were a generous gift from Dr.
Zalc. pEGFP was purchased from Clontech.
Cell Culture
Glial restricted precursors. GRPs from E13.5 rats were ob-
tained by using the method described in Rao et al. (1998). Briefly,
neural tubes were removed, cleaned, and dissociated by trypsiniza-
tion and mechanical trituration. The dissociated cells were plated
on poly-L-lysine/laminin-coated dishes. Cells were grown in a
37°C/5% CO2 incubator in NEP basal medium [DMEM-F12
supplemented with additives described by Bottenstein and Sato
(1979) and bFGF (35 ng/ml)].
To specifically obtain A2B5 cells, a modification of the specific
antibody capture assay was employed Wysocki and Sato (1978).
Briefly, the cells were trypsinized and plated onto a 100-mm petri
dish coated with the NCAM antibody for 2–3 h at 37°C to allow for
the maximum attachment of NRPs. The cells of the supernatant,
an enriched population of glial precursor cells, were plated onto
A2B5-coated dishes. Cells were allowed to bind to the dish for 1 h
at room temperature. The supernatant was discarded and the dish
was washed several times with PBS. The bound cells were scraped
off and plated onto poly-L-lysine/laminin-coated dishes in NEP
basal medium. Generally, the panning efficiency was greater than
90% as tested by immunocytochemistry.
GRP cell line. A GRP cell line has been generated which, when
maintained in certain conditions, will remain in an undifferenti-
ated state (Wu et al., 2002). These cells were maintained on
fibronectin-coated dishes in bFGF-containing NEP basal medium
supplemented with PDGF (10 ng/ml). Cells were passaged every
3–4 days.
NIH 3T3. The NIH 3T3 cells used in this study were grown on
uncoated culture dishes in DMEM containing 10% fetal calf serum,
1% pen-strep, and 1% glutamate.
Transient Transfection Assays
NIH 3T3 cells were transiently transfected by using Fugene 6
(Boehringer) with the following constructs: (1) pEGFP alone as a
control; (2) pLNCX–Ngn3/MT alone; (3) PLP–GFP alone; (4) GFAP–
GFP alone; (5) pLNCX–Ngn3/MT and PLP–GFP; and (6) pLNCX–
Ngn3/MT and GFAP–GFP. A total of 1 g of each plasmid was
transfected into each dish according to the manufacturer’s proto-
col. Two to three days posttransfection, cells were fixed in 2%
paraformaldehyde for 30 min at room temperature. GFP and MT
cells were counted by using the appropriate filters to detect
fluorescence.
RESULTS
Degenerate PCR Identifies the Expression of bHLH
mRNAs in Glial-Restricted Precursor Cells
GRPs are the earliest glial precursor cells present in the
developing spinal cord (Rao et al., 1998). To determine
whether bHLH genes were present in this population, we
used a degenerate RT-PCR primer strategy to amplify bHLH
genes expressed in GRPs. Immunopurified E13.5 rat GRP
cells grown 3 days in culture were used as a source of cDNA
for RT-PCR. Amplified products were cloned and se-
quenced. Only three known bHLH genes were isolated:
NeuroD, NeuroD2, and Ngn3 (Fig. 2A). To confirm the
presence of these three bHLH transcription factors in GRP
cells, specific primers to NeuroD, NeuroD2, and Ngn3 were
designed to amplify these genes from the immunopanned
E13.5 GRP cDNA. Again, the presence of these mRNAs in
GRP cells was corroborated by using sequence-specific
primers (Fig. 2B).
Immunopanning allowed us to obtain a relatively pure
population of glial precursors (90%). Therefore, it is likely
that the bHLH genes detected were expressed by glial
precursors. However, it is also possible that these genes
were expressed in the contaminating neuronal cells
(10%). To rule out this possibility, sister dishes were
stained for the neuronal markers NCAM and III tubulin.
No staining was observed on these immunopanned cells
(data not shown), suggesting that NeuroD, NeuroD2, and
Ngn3 were expressed by the glial precursors in culture. The
specificity of expression in glial cells was further confirmed
by using two independent sources of glial-specific cDNA.
cDNA from O2A cells and from an immortalized glial-
restricted precursor cell line (GRP CL) (Wu et al., 2002) was
isolated, and RT-PCR was performed by using primers
specific to NeuroD, NeuroD2, and Ngn3 to detect expres-
sion in these two populations. All three bHLH transcription
factors were detected in both cell types (Fig. 2C). The glial
character of the O2A and the GRP CL was confirmed by
detecting expression of neuronal and glial markers (Fig. 2D).
Nestin, an intermediate filament protein expressed in mul-
tipotent stem cells and precursor cells, and PLP/DM20, a
proteolipid protein (and its alternate splice form) expressed
by oligodendrocytes and their precursors, were present in
both glial cDNA populations. However, as expected, NF-M,
an intermediate filament protein specific to neurons, was
not detected except in control whole brain cDNA. GFAP, a
marker for astrocytes, was not detected in the GRP CL
cDNA but was detected in the O2A cells. The presence of
GFAP in the O2A cDNA suggests that some of the O2A
cells had differentiated into astrocytes. Primers for the
housekeeping gene glyceraldehyde-3-phosphate dehydroge-
nase (G3PDH) were used as a control for PCR, and G3PDH
was detected in all cDNAs tested.
Olig1 and olig2 were not detected in our screen, raising
the possibility that these genes were not expressed at this
stage of precursor cell development or in this particular
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glial lineage. To test this, we designed primers specific to
olig1 and olig2 and performed RT-PCR on cDNA derived
from GRP CL cells. In addition, we designed primers
specific to Nkx2.2 to determine whether it was expressed in
this population of glial precursor cells. We were able to
amplify olig1 and Nkx2.2, but not olig2, from this popula-
tion (Fig. 2E). Thus, it remains possible that the absence of
olig2 may be due to the stage of development of the cells.
The Domain of Ngn3 and Nkx2.2 Expression
Overlaps and Their Expression Does Not Correlate
with Known Neuronal Genes
Upon identification of these genes, we decided to further
investigate Ngn3 for several reasons: (1) it is expressed in
the ventral portion of the neural tube where gliogenesis is
believed to occur; (2) the onset of its expression precedes
gliogenesis suggesting a role in cell fate determination; and
(3) the function of Ngn3 in the spinal cord remains un-
known. We performed in situ hybridization to demonstrate
the expression pattern of Ngn3 as had been previously
described (Ravassard et al., 1997a; Sommer et al., 1996).
Ngn3 was expressed in a ventral domain of the developing
neural tube (Figs. 3A–3C); by E16.5, Ngn3 mRNA was
undetectable in the neural tube (Fig. 3D). Ngn3’s domain of
expression appeared to overlap with Nkx2.2, another gene
implicated in oligodendrogliogenesis (Figs. 3E and 3F) (Fu
and Qiu, 2001; Qi et al., 2001; Soula et al., 2001). Using
antibodies to both Nkx2.2 and Ngn3, we detected cells
expressing either transcription factor to be located within
the same ventral domain (Figs. 3G and 3H). In addition,
both Ngn3 (Fig. 3I) and Nkx2.2 (Liu et al., 2002) were
expressed in a domain distinct from sox10 expression.
Sox10, an early oligodendrocyte marker, is an HMG tran-
scription factor whose function is required for the proper
appearance of myelinating cells of the CNS and peripheral
nervous system (PNS) (Britsch et al., 2001; Stolt et al.,
2002).
To ascertain whether Ngn3 and Nkx2.2 cells express
neuronal markers, transverse mouse sections were double
stained for either Ngn3 or Nkx2.2 and known neuronal
FIG. 4. Loss of Ngn3 alters both Nkx2.2 and Sim1 expression in
the ventral neural tube. Immunohistochemistry and in situ hybrid-
ization was performed by using Nkx2.2 and Sim1, respectively, to
investigate what the effect of the loss of Ngn3 had on these
transcription factors. Nkx2.2 is clearly detected in both the control
(A) and knockout (B) Ngn3 sections at E9.5. At E11.5, Nkx2.2 was
again detected in both the control (C) and knockout (D) sections,
albeit less in the knockout. At E13.5, Nkx2.2 expression was
completely lost in the Ngn3/ sections (F) while present in control
sections (E). Like Nkx2.2, Sim1 was also present at E11.5 in both
genotypes (G, H), but much less Sim1 signal was observed in the
Ngn3 null animal (H), while at E13.5, Sim1 expression is absent in
the knockout sections (J) as opposed to the control sections (I). The
apparent loss of Nkx2.2-expressing and Sim1-expressing cells in
the Ngn3 null animal was not attributable to premature cell death
since TUNEL labeling showed no difference between the two
genotypes (K, L). DNase-treated Ngn3 control (K) and null (L)
sections were processed as a positive control for TUNEL labeling.
Scale bars, 50 m (C–J) and 100 m (K, L).
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markers. Neither of the two neuronal markers tested,
MAP2 or III tubulin (Ferreira et al., 1987; Ma et al., 1996),
colocalized with Nkx2.2 or Ngn3, respectively (Figs. 3J and
3K). Dissociated culture experiments also demonstrated
that III tubulin and Nkx2.2 were not coexpressed by the
same cells (Fig. 3L). We thus concluded that cells that
express Ngn3 and Nkx2.2 are nonneuronal cells based on
their lack of coexpression with known neuronal markers
and define a distinct domain in the ventral neural tube.
Since Ngn3 and Nkx2.2 cells did not coexpress neuro-
nal markers, we then asked whether these cells expressed
glial markers. RT-PCR was performed on acutely dissoci-
ated E14 rat GRPs in nondifferentiating culture conditions,
i.e., only bFGF, to demonstrate the transient nature of Ngn3
expression as opposed to the persistent nature of Nkx2.2
expression. At day 0, Ngn3 is clearly detected; however, we
were unable to detect Ngn3 expression at subsequent time
points (Fig. 3M). Unlike Ngn3, the level of Nkx2.2 mRNA
appears to increase when the cells are cultured for a
prolonged period of time (Fig. 3M). Due to the transient
FIG. 5. Isl1, Chx10, Pax6, and early glial precursor cell markers are not affected by the loss of Ngn3. To determine whether the loss of
Ngn3 affected select spinal cord regionalization markers, we performed immunohistochemistry on Ngn3 control and null sections. E11.5
transverse spinal cord sections from Ngn3 control and / mice were stained for the motor neuron marker Isl1 (A, D), the V2 interneuron
marker Chx10 (B, E), and Pax6 (C, F). No difference in expression was detected for any of these transcription factors in either genotype. To
ascertain whether Ngn3 was required for the appropriate expression of OLP markers, in situ hybridization using the olig2 (G, J), PDGFR
(H, K), and sox10 (I, L) probes was performed on E13.5 transverse spinal cord sections from Ngn3 control and null animals. All three markers
for OLPs were detected in the knockout sections, suggesting that their expression was not dependent on Ngn3. Scale bars, 100 m.
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nature of Ngn3 expression, we were unable to detect
Ngn3-immunopositive cells in culture; however, immuno-
cytochemical detection of Nkx2.2 was readily detectable in
acutely dissociated A2B5 immunopanned cultures (Fig.
3N). Taken together, these results suggest that Ngn3 and
Nkx2.2 are expressed in glial precursors and Nkx2.2 expres-
sion persists when differentiating into an oligodendrocyte
precursor or oligodendrocyte.
Nkx2.2 and Sim1 Expression Is Lost in the Ngn3
Knockout Animal
In addition to the spinal cord, Ngn3 and Nkx2.2 are both
expressed in the developing pancreas. In the pancreas, loss
of Ngn3 expression causes a loss of all four endocrine cell
types, whereas the loss of Nkx2.2 leads to the absence of
pancreatic  cells (Gradwohl et al., 2000; Sussel et al.,
1998). This suggests that Ngn3 acts upstream of Nkx2.2 in
the pancreatic developmental pathway. However, Briscoe et
al. (1999) demonstrate that, in the neural tube, the absence
of Nkx2.2 leads to a loss of Ngn3 expression, thereby
suggesting that Nkx2.2 is required for Ngn3 expression or
necessary for maintaining Ngn3 expression. To determine
what effect the loss of Ngn3 has on Nkx2.2 expression in
the spinal cord, Nkx2.2 immunohistochemistry on the
Ngn3 null animal was performed.
At E9.5, no difference in Nkx2.2 expression was observed
in either genotype (compare Figs. 4A and 4B). At E11.5,
Nkx2.2 expression was observed in both the Ngn3 control
and knockout sections, though notably reduced in the
knockout section (Figs. 4C and 4D). However, at E13.5,
Nkx2.2 expression was only observed in the Ngn3 control
sections (Fig. 4E); no expression was observed in the Ngn3
null sections (Fig. 4F). Thus, the maintenance of Nkx2.2
expression appears to be dependent on Ngn3 sometime after
E9.5.
In addition to the loss of Ngn3 expression, Sim1 expres-
sion was absent in the Nkx2.2 knockout animal (Briscoe et
al., 1999). Sim1, like Ngn3, is a transcription factor that has
been used to identify V3 interneurons of the ventral neural
tube. To ascertain whether Sim1 expression was also lost in
the absence of Ngn3, we performed Sim1 in situ hybridiza-
tion on Ngn3 control and / sections. While the Ngn3
null animal demonstrated fewer Sim1-expressing cells com-
pared with the control at E11.5 (compare Figs. 4G and 4H),
no Sim1-expressing cells were detected in the E13.5 knock-
out sections (compare Figs. 4I and 4J). TUNEL revealed that
the loss of both Nkx2.2- and Sim1-expressing cells was not
due to apoptosis at either E11.5 (Figs. 4K and 4L) or E13.5
(data not shown). Thus, expression of both Nkx2.2 and
Sim1 is gradually lost between E11.5 and E13.5 in the Ngn3
knockout mouse.
Expression of V2 and MN Domain Markers Is Not
Affected by the Absence of Ngn3
Several groups have now proposed that oligodendrocytes
and their precursors may arise from the same population of
cells that generate motor neurons (Kessaris et al., 2001;
Richardson et al., 1997, 2000). The origin of both oligoden-
drocytes and motor neurons is believed to be a population of
precursor cells residing in the ventral neural tube. Since the
loss of Ngn3 disrupted both Nkx2.2 and Sim1 expression,
we next looked at several spinal cord regionalization mark-
ers in the ventral neural tube at E11.5 to see whether their
expression was affected by the absence of Ngn3.
Motor neurons, derived from the pMN domain, exhibited
no observable difference between the control and knockout
animal as assessed by Isl1 immunoreactivity (Figs. 5A and
5D). Similar to Isl1, Chx10, a marker for V2 interneurons,
was observed in both the control and null Ngn3 sections
with no obvious disparity between the two (Figs. 5B and 5E).
Analysis of Pax6, a protein that demonstrates complemen-
tary expression with Nkx2.2 in the spinal cord, shows no
discernible difference between either genotype (Figs. 5C and
5F). Thus, except for the loss of V3 interneurons, the
absence of Ngn3 does not perturb neurogenesis, in particu-
lar motor neuron genesis.
Two domains of OLPs have been proposed based on the
expression patterns of Nkx2.2 and olig1/2 (Fu et al., 2002;
Liu et al., unpublished observations). We believe one do-
main to be Nkx2.2/Ngn3 while the other domain is
PDGFR/Sox10/Olig. Since the loss of Ngn3 caused an
alteration in Nkx2.2 expression, we sought to investigate
whether markers for the second domain of OLPs were
compromised. E13.5 Ngn3 sections were processed for in
situ hybridization by using riboprobes for sox10, PDGFR,
and olig2. No loss of olig2 (Figs. 5G and 5J), PDGFR (Figs.
5H and 5K), or sox10 (Figs. 5I and 5L) expression was
detected in the Ngn3 knockout sections as compared with
the control sections; in addition, olig2 expression appeared
to shift ventrally in the knockout animals, although this
has not been confirmed by double in situ hybridization.
These results are similar to the observations made by Qi et
al. (2001) in the Nkx2.2 null animal, where expression of
both olig2 and PDGFR was neither reduced nor delayed.
Thus, loss of Ngn3 only altered the expression of Nkx2.2
but not the markers characteristic of second domain of
OLPs.
The Appearance of Mature Oligodendrocyte
Markers Is Affected in the Ngn3 Knockout
Spinal Cord
The loss of Nkx2.2 has been previously reported to cause
defects in oligodendrogliogenesis (Qi et al., 2001). Specifi-
cally, the appearance of PLP and MBP is delayed and
reduced, while no difference in GFAP is reported. Since the
loss of Ngn3 resulted in a loss of Nkx2.2 expression, we
next sought to investigate whether the Ngn3 knockout
mouse also demonstrates a reduction in oligodendrocyte-
specific markers. These results were then compared with
sections from Nkx2.2 wild-type and null animals, upon
which the same experiments were performed. As previously
reported, expression of MBP was markedly reduced in P1
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Nkx2.2 null sections with respect to its wild-type litter-
mate (Qi et al., 2001) (Figs. 6A and 6B). Similarly, in the P0
Ngn3-deficient animals, MBP expression was dramatically
reduced compared with the wild-type sections (Figs. 6C and
6D). Immunohistochemistry using an antibody to MBP was
performed to confirm the in situ hybridization results;
again, more staining is seen in the wild-type sections as
opposed to the knockout sections (Figs. 6E and 6F).
To further support the finding that Ngn3 plays an impor-
tant role in the proper expression of oligodendrocyte mark-
ers, in situ hybridization using the PLP riboprobe was
performed. Similar to the results seen in the Nkx2.2 ani-
mals, the Ngn3 null animals displayed a significant reduc-
tion in the amount of PLP mRNA present at P0 (Figs. 6G
and 6H).
Effects of the Loss of Ngn3 on Astrocytic Markers
Since the loss of Nkx2.2 only affects oligodendrocytes, it
likely acts upon cells committed to becoming oligodendro-
cytes. If, however, Ngn3 is required for the maintenance of
Nkx2.2 expression in the neural tube, Ngn3 may act upon
the bipotential cell fated to become either astrocytes or
oligodendrocytes. Indeed, our initial PCR data suggest this
(see Fig. 2). Thus, we decided to investigate whether the loss
of Ngn3 affects the expression of GFAP and S100, two
markers for mature astrocytes. Compared with the wild-
type Ngn3 sections, a significant decrease of GFAP expres-
sion is observed in the Ngn3/ animals throughout the
spinal cord at E16.5 (Figs. 7A and 7B). GFAP expression
continued to be reduced in the spinal cord at E18 (Figs. 7C
and 7D). At both E16.5 and E18, GFAP expression within
the gray matter was noticeably diminished, while the fiber
staining in the white matter also appeared to be shorter. But
at P0, no significant difference was detected in GFAP (Figs.
7E and 7F). Similar to GFAP at E18, S100 expression
showed an observable difference between the control and
knockout sections (Figs. 7G and 7H). When analyzed at P0,
no disparity in S100 expression was observed in either
genotype (data not shown). In summary, Ngn3 appears to
have an effect on the early development of astrocytes, but at
later ages, the generation of astrocytes may occur indepen-
dent of Ngn3 or may be compensated by unknown compen-
satory mechanisms.
Ectopic Ngn3 Expression Can Drive Gene
Expression from the PLP Promoter but Not the
GFAP Promoter
Since loss of Ngn3 function appears to cause a reduction
in the appearance of both oligodendrocytes and astrocytes,
we sought to investigate whether Ngn3 could directly
regulate oligodendrocyte- and astrocyte-specific genes. To
do this, we transiently cotransfected NIH 3T3 cells with a
full-length, myc-tagged Ngn3 expression vector (Ngn3-MT)
and a PLP–GFP promoter reporter construct wherein a
fragment of the PLP promoter drives GFP expression. This
promoter fragment had been previously used to drive appro-
priate expression of lacZ in transgenic mice (Spassky et al.,
1998). Likewise, NIH 3T3 cells were also cotransfected
with the Ngn3-MT expression vector and a GFAP–GFP
promoter reporter construct wherein a fragment of the
GFAP promoter drives GFP expression. Analysis of the PLP
and GFAP promoter sequences identified several consensus
E-box binding sites.
When the Ngn3-MT construct was transfected into 3T3
cells alone, myc tag staining was readily seen (Fig. 8A); no
GFP cells were observed. When the PLP–GFP construct
was transfected alone, virtually no GFP expression was
detected (Figs. 8B and 8C). Similarly, when the GFAP–GFP
construct was transfected alone into 3T3 cells, GFP expres-
sion was undetectable (Figs. 8B and 8E). Myc tag expression
was not detected in dishes transfected with either PLP–GFP
or GFAP–GFP alone (Figs. 8C and 8E).
When both PLP–GFP and Ngn3–MT were cotransfected
into 3T3 cells, GFP expression was observed (Figs. 8B and
8D). Induction was initially seen 48 h after transfection and
increased over the next 24 h. Myc tag staining on the
cotransfected dishes clearly demonstrates GFP expression
in the ectopic Ngn3-expressing cells. However, in the
GFAP–GFP and Ngn3–MT cotransfection experiments,
very few cells expressing GFP were observed (Figs. 8B and
8F). Thus, it appears that Ngn3 can drive expression from
the PLP promoter but not the GFAP promoter in transient
transfection assays and further suggests that Ngn3 ex-
pression in glial precursors can drive expression of
oligodendrocyte-specific genes.
To eliminate the possibility that GFP expression was due
to Ngn3 first inducing Nkx2.2 expression, cells transfected
with Ngn3–MT and PLP–GFP or Ngn3-MT alone were
stained for Nkx2.2. In the PLP–GFP and Ngn3–MT cotrans-
fected dishes, Nkx2.2 was not detected in the GFP cells
(Fig. 8G). Similarly, Nkx2.2 was not detected in cells
transfected with Ngn3–MT alone (Fig. 8H). Thus, Ngn3
appears to directly activate expression of GFP from the PLP
promoter.
DISCUSSION
Ngn3 Is Expressed by Cells of the Glial Lineage
and Is Required for the Normal Appearance of
Both Astrocytes and Oligodendrocytes
In this report, we demonstrate that Ngn3 is expressed in
bipotential glial progenitor cells in a domain that overlaps
the domain of Nkx2.2 expression both spatially and tempo-
rally. Loss of Ngn3 expression leads to a loss of Nkx2.2
expression and a reduction of oligodendrocyte marker ex-
pression, while overexpression is sufficient to drive expres-
sion from an oligodendrocyte-specific promoter fragment.
Neuronal markers and markers for a second domain of
oligodendrocyte precursor cells were not affected by the
loss of Ngn3, but an alteration in GFAP expression was
noted in the Ngn3 null animal. Based on the timing of Ngn3
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FIG. 6. Loss of Ngn3 expression results in a reduction in the
expression of mature oligodendrocyte markers. In situ hybridiza-
tion (A–D) and immunohistochemistry (E, F) for MBP were per-
formed on transverse spinal cord sections of P0 Ngn3 and P1
Nkx2.2 wild type and null animals. A pronounced reduction of
MBP cells is seen in the P1 Nkx2.2 wild-type (A) vs knockout (B)
sections. In the wild-type P0 Ngn3 animal, MBP cells are clearly
detected in the white matter (C); far fewer MBP-expressing cells are
seen in the sections of the Ngn3 knockout animal (D). Antibody
staining further confirms the reduction of MBP expression in P0
Ngn3 animals when the wild-type sections (E) are compared with
the knockout sections (F). In situ hybridization using PLP, another
marker for mature oligodendrocytes, was also performed on P0
Ngn3 sections. Similar to MBP, PLP cells are observed in the
wild-type sections (G) but significantly diminished in the knockout
sections (H). Scale bars, 100 m.
FIG. 7. At early ages, the expression of GFAP is reduced in the
Ngn3 knockout animal, but at later ages, its expression appears
recovered. GFAP expression was observed throughout the spinal
cord in the wild-type E16.5 Ngn3 mouse sections (A), whereas, in
the Ngn3/ animal, expression was significantly reduced and
restricted to mainly the periphery of the neural tube (B). Even at
E18, GFAP expression still appears reduced in the knockout animal
(D) compared with the wild-type section (C). At P0, no measurable
difference in GFAP expression is detectable in the Ngn3 knockout
mouse as GFAP was detected in the both Ngn3 wild-type (E) and
null (F) sections. S100, another marker for astrocytes, was also
used to determine whether there was a difference in astrocytic
markers at the onset of astrogliogenesis. Similar to GFAP, a subtle
difference in S100 expression was seen between the wild-type (G)
and (H) section at E18. Scale bars, 100 m.
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expression and the phenotype observed, we suggest that
Ngn3 acts at an early stage in development to regulate both
astrocyte and oligodendrocyte differentiation.
Previous studies have implicated Ngn3 in promoting
ectopic neurogenesis and pancreatic endocrine cell devel-
opment (Ravassard et al., 1997b; Schwitzgebel et al., 2000).
Our present results suggest a role for Ngn3 in glial differ-
entiation, and several lines of evidence support this claim.
First, Ngn3 is detected in purified glial populations. Second,
loss of Ngn3 expression results in a reduction of GFAP and
MBP expression. Third, Ngn3 is capable of driving GFP
expression from a PLP promoter fragment in 3T3 cells.
Finally, loss of Ngn3 expression results in a loss of the early
oligodendrocyte marker Nkx2.2; loss of Nkx2.2, in turn,
results in a specific loss of oligodendrocyte markers with-
out apparent apoptosis, loss of neuronal markers, or
changes in early astrocyte marker expression (Qi et al.,
2001). Taken together, these results suggest that Ngn3
plays a direct role regulating gliogenesis.
Ngn3 and Nkx2.2 Define a Distinct Domain from
Which Both Oligodendrocytes and Astrocytes Arise
OLPs are thought to arise from ventral regions of the
neural tube where olig1/2 and PDGFR are expressed (Lu et
al., 2000; Pringle and Richardson, 1993; Zhou et al., 2000).
This domain is spatially distinct from the domain of
Nkx2.2 expression, which also defines a region from where
oligodendrocytes can arise (Qi et al., 2001; Soula et al.,
2001; Xu et al., 2000). Ngn3 is both spatially and temporally
expressed in the same ventral domain as Nkx2.2. Thus,
Ngn3/Nkx2.2 and olig2/sox10/PDGFR may define two
different regions from which oligodendrocytes may initially
arise (Fu et al., 2002; Liu et al., 2002). In the Ngn3 mutants,
a complete loss of mature astrocyte and oligodendrocyte
markers is probably not observed due to compensation of
olig2/sox10/PDGFR in the oligodendrocyte lineage and of
unknown factors in the astrocyte lineage. Indeed, we dem-
onstrate that the expression of these early oligodendrocyte
markers is normal in the Ngn3 null animals (Fig. 5).
A recent report by Mallon et al. (2002) further supports
the existence of two populations of oligodendrocyte pro-
genitors. They describe the existence of two populations of
NG2 cells: one that is EGFP and one that is not (with
EGFP under the control of the PLP promoter) (Mallon et al.,
2002). Their results support our hypothesis in that we see
NG2 cells which are Nkx2.2 and NG2 cells which are
PDGFR (Liu et al., 2002). While additional experiments
are necessary, it is likely that the two populations described
by Mallon et al. (2002) and our laboratory are indeed the
same.
FIG. 8. Ngn3 can drive the expression of GFP under the control of
the PLP promoter but not the GFAP promoter. NIH 3T3 cells were
transiently transfected with Ngn3–MT alone (A), PLP–GFP alone
(C), GFAP–GFP alone (E), Ngn3–MT & PLP–GFAP (D), and
Ngn3–MT & GFAP–GFP (F) to determine whether Ngn3 can drive
expression of GFP driven by either the PLP or GFAP promoter.
After 72 h, cells were fixed, stained for Ngn3—MT, and counted.
Few, if any, cells were GFP in the cells transfected with Ngn3–MT
alone (A), PLP–GFP alone (C), or GFAP–GFP alone (E). In the
presence of Ngn3–MT (red), the number of GFP cells is dramati-
cally increased in cells cotransfected with PLP–GFP (D) but not
with GFAP–GFP (F). Transfection of Ngn3-MT did not induce the
expression of Nkx2.2 as cells transfected with Ngn3–MT and
PLP–GFP (G) and Ngn3–MT alone (H) did not exhibit any Nkx2.2
cells. The constructs that were transfected are listed in the upper
right, while the antibodies used to stain the cells are listed in the
lower left. (B) A graphical representation of the experiments dem-
onstrates that only cells transfected with both Ngn3–MT and
PLP–GFP expressed a significant number of GFP cells (n  109).
Each transfection experiment was performed 4 times; for each
transfection experiment, 50 fields of cells were counted for GFP
cells. The number in the graph represents the average of GFP cells
from all of the experiments.
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The loss of Nkx2.2 results in a reduction and delay in the
appearance of oligodendrocyte-specific markers (Qi et al.,
2001), whereas we show that loss of Ngn3 results in a
reduction of both astrocyte and oligodendrocyte marker
expression. One explanation for this is that Ngn3 acts upon
bipotential glial progenitors, whereas Nkx2.2 solely acts
upon lineage-restricted OLPs. This is analogous to the
results seen in the pancreatic lineage: loss of Nkx2.2 results
in the loss of only pancreatic beta cells, while the Ngn3
knockout demonstrates a loss in all four pancreatic endo-
crine cells (Gradwohl et al., 2000; Sussel et al., 1998). The
loss of Nkx2.2 expression in the spinal cord in the Ngn3
knockout is thus consistent with published reports analyz-
ing pancreatic development. Our results further suggest
that Ngn3 is not required for the initial expression of
Nkx2.2, but rather for maintenance of Nkx2.2 expression.
Likewise, it is also possible that Nkx2.2 is required for
maintaining the expression of Ngn3, suggesting a reciprocal
rather than a strictly linear regulation of transcription.
Alternatively, Ngn3 and Nkx2.2 may act at different
stages within GRP development. According to our PCR
results, GRPs express Ngn3 transiently. When GRPs un-
dergo differentiation into oligodendrocytes and astrocytes,
it is possible that a subset of GRPs acquire both Nkx2.2 and
olig2 expression. This subset of Nkx2.2/olig2 GRPs can
then differentiate into oligodendrocytes while the subset
that are Nkx2.2 or olig2 GRPs differentiate into astro-
cytes or oligodendrocytes. Further experiments need to be
performed to determine the exact lineage relationship be-
tween Ngn3, Nkx2.2, and olig2 cells in gliogenesis.
Members of the Neurogenin Family of bHLH
Transcription Factors Do Not Function in the
Same Manner
Members of the neurogenin family of bHLH transcription
factors were previously thought to be neuronal determina-
tion genes whose expression precedes neuronal differentia-
tion genes such as NeuroD (Sommer et al., 1996). Recent
evidence suggests that neurogenins actually inhibit gliogen-
esis (Nieto et al., 2001; Sun et al., 2001b; Tomita et al.,
2000). Here, we show that Ngn3 may actually promote
gliogenesis. How can this be resolved in light of the other
data? First, it is possible that the function of Ngn3 is
context-dependent: in the absence of other proneural bHLH
proteins, Ngn3 may induce glial differentiation. Second,
Ngn3 does not necessarily have to function in the same
manner as Ngn1 in sequestering away the Smad transcrip-
tional complex to prevent activation of the STAT pathway.
Further studies investigating Ngn3 and its transcriptional
binding partners may provide the answers.
We have previously shown that a bipotential oligoden-
drocyte and astrocyte precursor is present in early develop-
ment. This precursor is A2B5, present in the ventral neural
tube, migrates dorsally, and is capable of generating oligo-
dendrocytes and astrocytes after transplantation into the
cortex or the spinal cord (Herrera et al., 2001; Rao et al.,
1998; Yang et al., 2000). Our results showing that loss of
Ngn3 affects both astrocyte and oligodendrocyte differen-
tiation provide additional evidence that such a precursor
exists and is present in the ventral domain of the spinal
cord. The bipotential precursor undergoes further differen-
tiation to generate unipotent precursors. Nkx2.2 expression
likely persists in the oligodendrocyte precursor and is
down-regulated in the astrocyte precursor under the influ-
ence of dorsalizing signals. Likely candidates for such
signals include BMP and LIF molecules, which have been
shown to bias glial precursors toward astrocyte differentia-
tion (Gross et al., 1996; Nakashima et al., 1999). It remains
to be determined whether Smad and BMP receptor knock-
outs alter astrocyte and oligodendrocyte lineages.
In summary, we have demonstrated that Ngn3 partici-
pates in the development of oligodendrocytes and astro-
cytes. Loss of Ngn3 results in the loss of Nkx2.2 expression
and also a reduction in MBP and GFAP expression. How-
ever, not all glial markers are affected, suggesting that other
transcription factors are also responsible for generating glia.
Our results not only suggest a role for bHLH proteins in
regulating the neuronal vs nonneuronal fate choice, but also
a role in determining the subtype of glial cell that is present.
The predominance of NeuroD and NeuroD2 present in
GRPs also suggests that these factors may participate in the
differentiation of a glial precursor to mature astrocytes and
oligodendrocytes. Further experiments are needed to pro-
vide a better understanding of the role of bHLH transcrip-
tion factors in gliogenesis.
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